Case Reports

Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy

Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA;
CHU Rennes, Department of Hematology, University of Rennes, Rennes, France;
CHU Rennes, Department of Hematology, University of Rennes, Rennes, France;
CHU Rennes, Department of Radiology, University of Rennes, Rennes, France;
CHU Rennes, Department of Neurology, University of Rennes, Rennes, France;
Kite, a Gilead company, Santa Monica, California, USA;
Kite, a Gilead company, Santa Monica, California, USA;
Kite, a Gilead company, Santa Monica, California, USA;
Kite, a Gilead company, Santa Monica, California, USA;
Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA;
Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA;
Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
Dept of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA;
CHU Rennes, Department of Hematology, University of Rennes, Rennes, France;
Haematologica Early view Jul 30, 2020 https://doi.org/10.3324/haematol.2020.259952